about
Biomarkers of disease differentiation: HCV recurrence versus acute cellular rejection.Nephro and neurotoxicity of calcineurin inhibitors and mechanisms of rejections: A review on tacrolimus and cyclosporin in organ transplantationHepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.Follow-Up of Alcohol Consumption After Liver Transplantation: Interest of an Addiction Team?Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of the liver transplant patient.
@en
Management of the liver transplant patient.
@nl
type
label
Management of the liver transplant patient.
@en
Management of the liver transplant patient.
@nl
prefLabel
Management of the liver transplant patient.
@en
Management of the liver transplant patient.
@nl
P2860
P356
P1476
Management of the liver transplant patient.
@en
P2093
Bruce Gelb
Sandy Feng
P2860
P304
P356
10.1586/EGH.09.58
P577
2009-12-01T00:00:00Z